Since PUFA biosynthesis and STING signaling play important roles in other tissues outside of the hematopoietic system, additional in vivo studies using animal models of AML will be needed to assess the safety and effectiveness of targeting FADS enzymes and/or STING. Here, STING1 is linked to acute myeloid leukemia.